Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments

Biochemical and Biophysical Research Communications

Volumn 384, Issue 2, 2009, Pages 243-248

  Tiburu, Elvis K ^a   Tyukhtenko, Sergiy ^a   Deshmukh, Lalit ^b   Vinogradova, Olga ^b   Janero, David R ^a   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Agonist ligand; Conformational switch; G protein coupled receptor; High resolution NMR; Peptide helix; Proline; Spectrofluorometry; Structural biology; Transmembrane protein; Tryptophan

Indexed keywords

CANNABINOID 2 RECEPTOR; LEUCINE; SYNTHETIC PEPTIDE; TRYPTOPHAN;

ALPHA HELIX; ARTICLE; HUMAN; HYDROGEN BOND; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MOTIF; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, CANNABINOID, CB2; TRYPTOPHAN;

EID: 65549091123     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.099     Document Type: Article

References (40)

1. Hanson M.A., and Stevens R.C. Discovery of new GPCR biology: one receptor structure at a time. Structure 17 (2009) 8-14
2. 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276 (2001) 29171-29177
3. 2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277 (2002) 40989-40996
4. Bhattacharya S., Hall S.E., and Vaidehi N. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. J. Mol. Biol. 382 (2008) 539-555
5. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obesity 30 Suppl. 1 (2006) 13-18
6. Vemuri V.K., Janero D.R., and Makriyannis A. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome. Physiol. Behav. 93 (2008) 671-686
7. Janero D.R., Vadivel S.K., and Makriyannis A. Pharmacotherapeutic modulation of the endocannabinoid signaling system in psychiatric disorders: drug-discovery strategies. Int. Rev. Psychiatry 21 (2009) 122-133
8. Kapur A., Hurst D.P., Fleischer D., Whitnell R., Thakur G.A., Makriyannis A., Reggio P.H., and Abood M.E. Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7. Mol. Pharmacol. 71 (2007) 1512-1524
9. Nebane N.M., Hurst D.P., Carrasquer C.A., Qiao Z., Reggio P.H., and Song Z.H. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor. Biochemistry 47 (2008) 13811-13821
10. Picone R.P., Khanolkar A.D., Xu W., Ayotte L.A., Thakur G.A., Hurst D.P., Abood M.E., Reggio P.H., Fournier D.J., and Makriyannis A. (-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor. Mol. Pharmacol. 68 (2005) 1623-1635
11. Singh R., Hurst D.P., Barnett-Norris J., Lynch D.L., Reggio P.H., and Guarnieri F. Activation of the cannabinoid CB1 receptor may involve a W6.48/F3.36 rotamer toggle switch. J. Pept. Res. 60 (2002) 357-370
12. Montero C., Campillo N.E., Goya P., and Páez J.A. Homology models of the cannabinoid CB1 and CB2 receptors: a docking analysis study. Eur. J. Med. Chem. 40 (2005) 75-83
13. Ahston J.C., Wright J.L., McPartland J.M., and Tyndall J.D. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Curr. Med. Chem. 15 (2008) 1428-1443
14. Gong X.M., Franzin C.M., Thai K., Yu J., and Marassi F.M. Nuclear magnetic resonance structural studies of membrane proteins in micelles and bilayers. Methods Mol. Biol. 400 (2007) 515-529
15. Wang G. NMR of membrane-associated peptides and proteins. Curr. Protein Pept. Sci. 9 (2008) 50-69
16. Roccatano D., Colombo G., Fioroni M., and Mark A.E. Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study. Proc. Natl. Acad. Sci. USA 99 (2002) 12179-12184
17. Roth C.B., Hanson M.A., and Stevenson R.C. Stabilization of the human β2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue on GPCR structure. J. Mol. Biol. 376 (2008) 1305-1319
18. Garavito R.M., and Ferguson-Miller S. Detergents as tools in membrane biochemistry. J. Biol. Chem. 276 (2001) 2403-32406
19. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 31 (1998) 297-355
20. Chang C.T., Wu C.-S., and Yang J.T. Circular dichroism analysis of protein conformation inclusion of the β-turns. Anal. Biochem. 91 (1978) 13-31
21. Martin S.R., and Schilstra M.J. Circular dichroism and its application to the study of biomolecules. Methods Cell Biol. 84 (2008) 263-293
22. Gronwald W., Moussa S., Elsner R., Jung A., Ganslmeier B., Trenner J., Kremer W., Neidig K.P., and Kalbitzer H.R. Automated assignment of NOESY NMR spectra using a knowledge based method (KNOWNOE). J. Biomol. NMR 23 (2002) 271-287
23. Schwieters C.D., Kuszewski J.J., Tjandra N., and Clore G.M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160 (2003) 65-73
24. Linge J.P., Williams M.A., Spronk C.A., Bonvin A.M., and Nilges M. Refinement of protein structures in explicit solvent. Proteins 50 (2003) 496-506
25. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. B Biol. Crystallogr. 54 (1998) 905-921
26. Jung J.W., Yee A., Wu B., Arrowsmith C.H., and Lee W. Solution structure of YKR049C, a putative redox protein from Saccharomyces cerevisiae. J. Biochem. Mol. Biol. 38 (2005) 550-554
27. Laskowski R.A., Moss D.S., and Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231 (1993) 1049-1067
28. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14 (1996) 51-55 (29-32)
29. Landolt-Marticorena C., Williams K.A., Deber C.M., and Reithmeier R.A. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J. Mol. Biol. 229 (1993) 602-608
30. Walters J., Milam S.J., and Clark A.C. Practical approaches to protein folding and assembly: spectroscopic strategies in thermodynamics and kinetics. Methods Enzymol. 455 (2009) 1-39
31. Ma D., Liu Z., Li P., Tang P., and Xu Y. Structure and dynamics of the second and third transmembrane domains of human glycine receptor. Biochemistry 44 (2005) 8790-8800
32. 2-adrenoceptor. Nat. Chem. Biol. 2 (2006) 417-422
33. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
34. 2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
35. 1-adrenergic G-protein-coupled receptor. Nature 454 (2008) 486-491
36. Lagerstrom M.C., and Schioth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7 (2008) 339-357
37. Reggio P.H. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J. 8 (2006) E322-E336
38. Marsh D. Protein modulation of lipids, and vice versa, in membranes. Biochim. Biophys. Acta 1778 (2008) 1545-1575
39. Tiburu E., Bowman A.L., Struppe J.O., Janero D.R., Avraham H.K., and Makriyannis A. Solid-state and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes. Biochim. Biophys. Acta 1788 (2009) 1159-1167
40. Pei Y., Mercier R.W., Anday J.K., Thakur G.A., Zvonok A.M., Hurst D., Reggio P.H., Janero D.R., and Makriyannis A. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling of GPCR activation. Chem. Biol. 15 (2008) 1207-1219